Vector Models and Indexing for Recombinant Protein Pharmacovigilance

Recombinant protein pharmacovigilance data originates from clinical trial reports, real-world studies, adverse event reporting systems (e.g., MedDRA

Data Characteristics

Recombinant protein pharmacovigilance data originates from clinical trial reports, real-world studies, adverse event reporting systems (e.g., MedDRA, WHO-UMC VigiBase), and published literature. This data often combines structured formats (e.g., database records, XML) and unstructured formats (e.g., free-text descriptions, PDF documents). The update frequency is high, especially during initial drug launch and Phase IV clinical trials, with a continuous influx of adverse event reports. Document lengths vary significantly, from short adverse event reports of a few dozen characters to clinical trial summaries spanning thousands of characters. Fields include general patient information, drug information, and adverse event descriptions, as well as recombinant protein-specific details such as expression system, purification process, and batch number. Units involve dosage (mg/kg), frequency (times/day), and duration (days).

Constraints on Vector Models and Indexing

The multi-source and mixed-structure nature of recombinant protein pharmacovigilance data imposes specific requirements on vector models and indexing. Medical terminology, abbreviations, and non-standard expressions in free-text descriptions require vector models with strong semantic understanding to capture deep relationships between words. High update frequency demands that the indexing system supports efficient incremental updates, avoiding frequent full rebuilds to ensure timely recall. Varying document lengths necessitate flexible chunking strategies. This avoids context loss from chunks that are too short and prevents dilution of key information from chunks that are too long. Effective embedding of recombinant protein-specific fields (e.g., expression system) improves retrieval accuracy. This is crucial for distinguishing adverse reaction differences potentially caused by different batches or production processes.

Configuration Settings

Configuration ItemRecommended ValueRationale
Chunk size512–768 charactersBalances contextual completeness and vector model processing efficiency, suitable for most adverse event descriptions.
Chunk Overlap Length128 charactersEnsures semantic continuity at chunk boundaries, preventing critical information from being cut off.
embedding_modeltext-embedding-ada-002 or m3ePossesses strong semantic understanding in the medical domain, suitable for multilingual and specialized terminology.
Recall countTop 20 entriesEnsures broad initial recall, providing sufficient candidates for subsequent re-ranking and filtering.
Similarity threshold0.75Balances relevance and exclusion of irrelevant information. Adjust based on actual recall performance.
maxContext4096 tokensEnsures enough chunk information can be accommodated when processing long documents, preventing truncation.

Common Pitfalls

  • Locally deployed vector model returns a 404 error after addition: This typically indicates an incorrect ONEAPI_BASE_URL configuration or that the model service is not running correctly, preventing FastGPT from accessing the model interface.
  • m3e model fails to load in a non-GPU environment: Possible reasons include Docker container not correctly mounting the model file path, or the MODEL_PATH environment variable not pointing to the correct model weight file.
  • Partial data missing during knowledge base export: This often occurs because export granularity only supports the knowledge base dimension. Fine-grained filtering by field or data type is not available, leading to unexpected content being bundled or omitted.

Verification Steps

  • Upload test documents containing recombinant protein adverse reaction descriptions. Check logs for Embedding success messages and confirm vector generation without errors.
  • Perform keyword and semantic queries on uploaded documents. Verify the relevance of returned results under Recall count and Similarity threshold. Manually evaluate the reasonableness of the threshold.
  • In the Knowledge Base interface, check if the knowledge base capacity and document count match the actual imported data volume. Ensure all data has been successfully indexed.
  • Use API calls to test recombinant protein-related texts of varying lengths and formats. Observe response times to evaluate the performance impact of the maxContext configuration.

The values provided are common starting points and should be measured against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.